H2561B3883A07134 AJB:JMT 09/14/20 #90 A07134
AMENDMENTS TO HOUSE BILL NO. 2561
Sponsor: REPRESENTATIVE SCHLEGEL CULVER
Printer's No. 3883
Amend Bill, page 2, line 1, by inserting after "of"
topical and oral
Amend Bill, page 2, lines 2 and 3, by striking out "Food and
Drug" in line 2 and all of line 3 and inserting
board as provided in section 4.3
Amend Bill, page 2, line 19, by striking out ", prevention"
Amend Bill, page 2, line 28, by inserting after "drugs"
, either by topical or oral routes of administration,
Amend Bill, page 2, lines 29 and 30, by striking out
"diseases and conditions affecting "
Amend Bill, page 2, line 30, by striking out "and adnexa"
Amend Bill, page 2, line 30, by inserting after "adnexa,"
the eyelids, the lacrimal system and the
conjunctiva ,
Amend Bill, page 3, line 1, by striking out the period after
"combinations" and inserting
, so long as the treatment of diseases or conditions
of the visual system, other than glaucoma, dry eyes or
allergies, as authorized under this paragraph shall not
continue beyond six weeks from the initiation of
treatment unless the prescribing optometrist documents
consultation with a licensed physician. As used in this
paragraph, the initiation of treatment may, but need not,
include the prescription or administration of
pharmaceutical agents for therapeutic purposes.
Amend Bill, page 3, line 4, by inserting after "bodies"
from the ocular surface or adnexa
2020/90AJB/HB2561A07134 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Amend Bill, page 3, lines 5 and 6, by striking out all of
line 5 and "(v)" in line 6 and inserting
(iv)
Amend Bill, page 3, line 7, by striking out "(vi)" and
inserting
(v)
Amend Bill, page 3, line 8, by striking out the period after
"imaging" and inserting
, which shall only include optical coherence
tomography.
Amend Bill, page 3, line 9, by striking out all of said line
and inserting
(vi) The administration and prescription of all
legend and nonlegend drugs approved by the board under
section 4.3 for the treatment of glaucoma.
[
Amend Bill, page 3, line 11, by striking out the bracket
before "as"
Amend Bill, page 3, line 12, by striking out the bracket
after "4.3"
Amend Bill, page 3, lines 16 and 17, by striking out "dry
eyes or allergies, "
Amend Bill, page 3, line 24, by striking out the bracket
before "(3)"
Amend Bill, page 4, line 7, by inserting after "diagnostic,"
exploratory,
Amend Bill, page 4, line 8, by inserting after "cosmetic,"
reconstructive,
Amend Bill, page 4, line 8, by inserting after "refractive"
, light-based
Amend Bill, page 4, line 8, by inserting after "surgery"
2020/90AJB/HB2561A07134 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
; or the use of lasers for therapeutic purposes
Amend Bill, page 4, lines 13 and 14, by striking out "and any
drugs approved by the board in section 4.3 for the treatment of
ocular disease"
Amend Bill, page 4, line 15, by inserting after "The"
prevention and
Amend Bill, page 5, line 14, by inserting after "drugs"
for only topical or oral routes of administration, with
the exception of drugs classified as chemotherapy drugs,
Amend Bill, page 5, line 24, by inserting after
"Commonwealth"
if the procedures and tests are within the scope of practice
of the optometrist
2020/90AJB/HB2561A07134 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
See A07134 in
the context
of HB2561